Effect of Sharbat Anar Sheerin in comparision with Ferrous Ascorbate in iron deficiency anemia during pregnancy-A randomised controlled trial

Effect of Sharbat Anar Sheerin versus Ferrous Ascorbate in iron deficiency anemia during pregnancy- A randomized controlled trial - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/01/078969

Enrollment

Registered

2025-01-20

Start date

Unknown

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D508- Other iron deficiency anemias

Interventions

Intervention1: Sharbat Anar sheerin: 25ml sharbat will be administered orally twice daily after meals for 8 weeks. Control Intervention1: Tablet Ferrous Ascorbate 100mg : Tablet Ferrous Ascorbate 10

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant women in the age group of 18 to 40 years, having singleton pregnancy between 13 to 26 weeks of gestation with mild to moderate anemia (Hb 7-10.9g/dl) with or without symptoms of dyspnoea, oedema, weakness, anorexia and fatigue.

Exclusion criteria

Exclusion criteria: Pregnant women with systemic illnesses e.g HTN (systolic BP =140mmHg and diastolic BP =90mmHg),DM (FBS=95mg/dl),TD, multiple gestation and anemia due to other causes like hemolytic anemia and hemorrhagic anemia .

Design outcomes

Primary

Measure	Time frame
Improvement in Hb%, Peripheral smear and Hematocrit valueTimepoint: baseline and 8 weeks	—

Secondary

Measure	Time frame
No secondary outcomeTimepoint: Not Applicable	—

Countries

India

Contacts

Public ContactProf Ismath Shameem

National Institute of Unani Medicine

dr.ismaths@gmail.com9449977008

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026